| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 5.80% |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Novel Drug Delivery Systems (NDDS) Market Analysis by Mordor Intelligence
The North America Novel Drug Delivery Systems Market is expected to register a CAGR of 5.8% during the forecast period.
The major factors for the growth of the market include the growing need of controlled release of drugs, and technological advancements promoting the development of NDDS. Most of the drugs have an optimum concentration range and requirement of controlled release of drugs in the body. Concentrations above or below the prescribed range can be toxic or can produce no therapeutic benefits. Transdermal patches, nasal systems, microcapsules, etc., are some of the common systems that are considered under the controlled release systems. Hence, the requirement of the controlled release of drugs drives the novel drug delivery systems market. The stability of a delivery system is one of the most important factors that affect the drug delivery systems market. The restraining factors include stringent regulatory guidelines and product recalls.
North America Novel Drug Delivery Systems (NDDS) Market Trends and Insights
Oral Drug Delivery Systems is Expected to Grow Fastest during the Forecast Period
Oral drug delivery has found to be the most preferred and convenient route of drug administration, due to high patient compliance, cost-effectiveness, least sterility constraints, flexibility in the design of dosage form, and ease of production. In oral administration, drugs should be protected under unstable biological environments, including drug degradation induced by the GI tract and first-pass liver effects after oral administration before reaching the targeted sites. The oral drug delivery is majorly driven by the increasing incidence of chronic diseases, reformulation and repositioning of drugs using advanced oral delivery systems, and huge investments made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies. According to Globocan, 2018 there were a total of 2,129,118 incident cancers in the United States for the year 2018.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The market players are focusing on the development of innovative treatment options in order to grab maximum market share. Some of the market players are Abbott Laboratories, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi SA
North America Novel Drug Delivery Systems (NDDS) Industry Leaders
-
Abbott Laboratories
-
Roche Holding AG
-
Merck & Co.
-
GlaxoSmithKline PLC
-
Bayer AG
- *Disclaimer: Major Players sorted in no particular order
_Market.webp "North America Novel Drug Delivery Systems (NDDS) Market Concentration")
Need More Details on Market Players and Competitors?
Download PDF
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
North America Novel Drug Delivery Systems (NDDS) Market Report Scope
As per the scope of this report, the novel drug delivery system (NDDS) is intended to increase the efficacy of drugs. NDDSs are adopted to increase the bioavailability of the drug, to reduce adverse effects and side effects, and increase drug stability. The market is segmented by route of administration, mode of NDDS, and geography.
By Route of Administration
| Oral Drug Delivery Systems |
| Injectable Drug Delivery Systems |
| Pulmonary Drug Delivery Systems |
| Transdermal Drug Delivery Systems |
| Others |
By Mode of NDDS
| Targeted Drug Delivery Systems |
| Controlled Drug Delivery Systems |
| Modulated Drug Delivery Systems |
Geography
| North America | United States |
| Canada | |
| Mexico |
| By Route of Administration | Oral Drug Delivery Systems | |
| Injectable Drug Delivery Systems | ||
| Pulmonary Drug Delivery Systems | ||
| Transdermal Drug Delivery Systems | ||
| Others | ||
| By Mode of NDDS | Targeted Drug Delivery Systems | |
| Controlled Drug Delivery Systems | ||
| Modulated Drug Delivery Systems | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current North America Novel Drug Delivery Systems (NDDS) Market size?
The North America Novel Drug Delivery Systems (NDDS) Market is projected to register a CAGR of 5.8% during the forecast period (2025-2030)
Who are the key players in North America Novel Drug Delivery Systems (NDDS) Market?
Abbott Laboratories, Roche Holding AG, Merck & Co., GlaxoSmithKline PLC and Bayer AG are the major companies operating in the North America Novel Drug Delivery Systems (NDDS) Market.
What years does this North America Novel Drug Delivery Systems (NDDS) Market cover?
The report covers the North America Novel Drug Delivery Systems (NDDS) Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Novel Drug Delivery Systems (NDDS) Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
North America Novel Drug Delivery Systems (NDDS) Market Report
Statistics for the 2025 North America Novel Drug Delivery Systems (NDDS) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Novel Drug Delivery Systems (NDDS) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
